{"id":14003,"date":"2018-02-23T07:39:07","date_gmt":"2018-02-23T07:39:07","guid":{"rendered":"https:\/\/arisglobal.com\/bkp-site\/?p=14003"},"modified":"2018-02-23T07:39:07","modified_gmt":"2018-02-23T07:39:07","slug":"whitepaper-national-pharmacovigilance-systems-role-technology-bridging-disparities","status":"publish","type":"post","link":"https:\/\/www.arisglobal.com\/blogs\/whitepaper-national-pharmacovigilance-systems-role-technology-bridging-disparities\/","title":{"rendered":"National Pharmacovigilance Systems &#038; Role of Technology in Bridging the Disparities"},"content":{"rendered":"\n\n\nA typical framework for a pharmacovigilance (PV) system at the national level includes a primary national regulatory body and several regional centers\/ national centers. Across the spectrum of WHO classi\ufb01cation of low and middle-income countries (LMIC) and high-income countries, ArisGlobal assessed the pharmacovigilance requirements in a randomly selected set of 20 countries and determined a ranking of Advanced, Emerging and Rudimentary categorizations of these countries\u2019 PV capabilities.\n\nRegardless of its assessment, how can any nation improve its ranking? This white paper explores today\u2019s national pharmacovigilance systems and the role of technology in bridging the gaps in drug safety of regulatory authorities around the world. <\/br>\n<ul>Download this whitepaper to learn about: \n \t<li>Pharmacovigilance with an \u2018e\u2019 \u2013 the \u201c4pt-classification\u201d of the state of evolution of national pharmacovigilance systems<\/li>\n \t<li>Modern technologies in pharmacovigilance system \u2013 the way forward for national PV systems<\/li>\n \t<li>Advanced pharmacovigilance technologies \u2013the role \u2018e- enablement\u2019 technology plays in bridging the gaps in pharmacovigilance of regulatory authorities across the world<\/li>\n<\/ul>\n<a class=\"button\" href=\"https:\/\/resources.arisglobal.com\/lifesphere-safety\/national-pharmacovigilance-systems-role-of-technology-in-bridging-the-disparities\">Download Whitepaper<\/a>\n","protected":false},"excerpt":{"rendered":"<p>Download this white paper to learn about.<\/p>\n<p>Pharmacovigilance with an \u2018e\u2019 \u2013 the \u201c4pt-classification\u201d of the state of evolution of national pharmacovigilance systems<br \/>\nModern technologies in pharmacovigilance system \u2013 the way forward for national PV systems<br \/>\nAdvanced pharmacovigilance technologies \u2013the role \u2018e- enablement\u2019 technology plays in bridging the gaps in pharmacovigilance of regulatory authorities across the world<\/p>\n","protected":false},"author":27,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[67],"tags":[],"class_list":["post-14003","post","type-post","status-publish","format-standard","hentry","category-blogs"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.4 (Yoast SEO v23.9) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Whitepaper: National Pharmacovigilance Systems &amp; Role of Technology in Bridging the Disparities | ArisGlobal<\/title>\n<meta name=\"description\" content=\"The framework for a pharmacovigilance system at the national level includes a primary national regulatory body and several regional centers\/ national centers. This whitepaper explores today\u2019s national pharmacovigilance systems and the role of technology in bridging the gaps in drug safety of regulatory authorities\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.arisglobal.com\/whitepaper\/whitepaper-national-pharmacovigilance-systems-role-technology-bridging-disparities\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"National Pharmacovigilance Systems &amp; Role of Technology in Bridging the Disparities\" \/>\n<meta property=\"og:description\" content=\"The framework for a pharmacovigilance system at the national level includes a primary national regulatory body and several regional centers\/ national centers. This whitepaper explores today\u2019s national pharmacovigilance systems and the role of technology in bridging the gaps in drug safety of regulatory authorities\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.arisglobal.com\/whitepaper\/whitepaper-national-pharmacovigilance-systems-role-technology-bridging-disparities\/\" \/>\n<meta property=\"og:site_name\" content=\"ArisGlobal\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/LifeSphereAG\/\" \/>\n<meta property=\"article:published_time\" content=\"2018-02-23T07:39:07+00:00\" \/>\n<meta name=\"author\" content=\"Mladen Prenc\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Mladen Prenc\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.arisglobal.com\/whitepaper\/whitepaper-national-pharmacovigilance-systems-role-technology-bridging-disparities\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.arisglobal.com\/whitepaper\/whitepaper-national-pharmacovigilance-systems-role-technology-bridging-disparities\/\"},\"author\":{\"name\":\"Mladen Prenc\",\"@id\":\"https:\/\/www.arisglobal.com\/#\/schema\/person\/bb2c7aafe44a090bcd667448651eb974\"},\"headline\":\"National Pharmacovigilance Systems &#038; Role of Technology in Bridging the Disparities\",\"datePublished\":\"2018-02-23T07:39:07+00:00\",\"dateModified\":\"2018-02-23T07:39:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.arisglobal.com\/whitepaper\/whitepaper-national-pharmacovigilance-systems-role-technology-bridging-disparities\/\"},\"wordCount\":171,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.arisglobal.com\/#organization\"},\"articleSection\":[\"Blog\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.arisglobal.com\/whitepaper\/whitepaper-national-pharmacovigilance-systems-role-technology-bridging-disparities\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.arisglobal.com\/whitepaper\/whitepaper-national-pharmacovigilance-systems-role-technology-bridging-disparities\/\",\"url\":\"https:\/\/www.arisglobal.com\/whitepaper\/whitepaper-national-pharmacovigilance-systems-role-technology-bridging-disparities\/\",\"name\":\"Whitepaper: National Pharmacovigilance Systems & Role of Technology in Bridging the Disparities | ArisGlobal\",\"isPartOf\":{\"@id\":\"https:\/\/www.arisglobal.com\/#website\"},\"datePublished\":\"2018-02-23T07:39:07+00:00\",\"dateModified\":\"2018-02-23T07:39:07+00:00\",\"description\":\"The framework for a pharmacovigilance system at the national level includes a primary national regulatory body and several regional centers\/ national centers. This whitepaper explores today\u2019s national pharmacovigilance systems and the role of technology in bridging the gaps in drug safety of regulatory authorities\",\"breadcrumb\":{\"@id\":\"https:\/\/www.arisglobal.com\/whitepaper\/whitepaper-national-pharmacovigilance-systems-role-technology-bridging-disparities\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.arisglobal.com\/whitepaper\/whitepaper-national-pharmacovigilance-systems-role-technology-bridging-disparities\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.arisglobal.com\/whitepaper\/whitepaper-national-pharmacovigilance-systems-role-technology-bridging-disparities\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.arisglobal.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"National Pharmacovigilance Systems &#038; Role of Technology in Bridging the Disparities\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.arisglobal.com\/#website\",\"url\":\"https:\/\/www.arisglobal.com\/\",\"name\":\"ArisGlobal\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.arisglobal.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.arisglobal.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.arisglobal.com\/#organization\",\"name\":\"LifeSphere\",\"url\":\"https:\/\/www.arisglobal.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.arisglobal.com\/#\/schema\/logo\/image\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"LifeSphere\"},\"image\":{\"@id\":\"https:\/\/www.arisglobal.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/LifeSphereAG\/\",\"https:\/\/www.linkedin.com\/products\/aris-global-lifesphere\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.arisglobal.com\/#\/schema\/person\/bb2c7aafe44a090bcd667448651eb974\",\"name\":\"Mladen Prenc\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Whitepaper: National Pharmacovigilance Systems & Role of Technology in Bridging the Disparities | ArisGlobal","description":"The framework for a pharmacovigilance system at the national level includes a primary national regulatory body and several regional centers\/ national centers. This whitepaper explores today\u2019s national pharmacovigilance systems and the role of technology in bridging the gaps in drug safety of regulatory authorities","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.arisglobal.com\/whitepaper\/whitepaper-national-pharmacovigilance-systems-role-technology-bridging-disparities\/","og_locale":"en_US","og_type":"article","og_title":"National Pharmacovigilance Systems & Role of Technology in Bridging the Disparities","og_description":"The framework for a pharmacovigilance system at the national level includes a primary national regulatory body and several regional centers\/ national centers. This whitepaper explores today\u2019s national pharmacovigilance systems and the role of technology in bridging the gaps in drug safety of regulatory authorities","og_url":"https:\/\/www.arisglobal.com\/whitepaper\/whitepaper-national-pharmacovigilance-systems-role-technology-bridging-disparities\/","og_site_name":"ArisGlobal","article_publisher":"https:\/\/www.facebook.com\/LifeSphereAG\/","article_published_time":"2018-02-23T07:39:07+00:00","author":"Mladen Prenc","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Mladen Prenc","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.arisglobal.com\/whitepaper\/whitepaper-national-pharmacovigilance-systems-role-technology-bridging-disparities\/#article","isPartOf":{"@id":"https:\/\/www.arisglobal.com\/whitepaper\/whitepaper-national-pharmacovigilance-systems-role-technology-bridging-disparities\/"},"author":{"name":"Mladen Prenc","@id":"https:\/\/www.arisglobal.com\/#\/schema\/person\/bb2c7aafe44a090bcd667448651eb974"},"headline":"National Pharmacovigilance Systems &#038; Role of Technology in Bridging the Disparities","datePublished":"2018-02-23T07:39:07+00:00","dateModified":"2018-02-23T07:39:07+00:00","mainEntityOfPage":{"@id":"https:\/\/www.arisglobal.com\/whitepaper\/whitepaper-national-pharmacovigilance-systems-role-technology-bridging-disparities\/"},"wordCount":171,"commentCount":0,"publisher":{"@id":"https:\/\/www.arisglobal.com\/#organization"},"articleSection":["Blog"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.arisglobal.com\/whitepaper\/whitepaper-national-pharmacovigilance-systems-role-technology-bridging-disparities\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.arisglobal.com\/whitepaper\/whitepaper-national-pharmacovigilance-systems-role-technology-bridging-disparities\/","url":"https:\/\/www.arisglobal.com\/whitepaper\/whitepaper-national-pharmacovigilance-systems-role-technology-bridging-disparities\/","name":"Whitepaper: National Pharmacovigilance Systems & Role of Technology in Bridging the Disparities | ArisGlobal","isPartOf":{"@id":"https:\/\/www.arisglobal.com\/#website"},"datePublished":"2018-02-23T07:39:07+00:00","dateModified":"2018-02-23T07:39:07+00:00","description":"The framework for a pharmacovigilance system at the national level includes a primary national regulatory body and several regional centers\/ national centers. This whitepaper explores today\u2019s national pharmacovigilance systems and the role of technology in bridging the gaps in drug safety of regulatory authorities","breadcrumb":{"@id":"https:\/\/www.arisglobal.com\/whitepaper\/whitepaper-national-pharmacovigilance-systems-role-technology-bridging-disparities\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.arisglobal.com\/whitepaper\/whitepaper-national-pharmacovigilance-systems-role-technology-bridging-disparities\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.arisglobal.com\/whitepaper\/whitepaper-national-pharmacovigilance-systems-role-technology-bridging-disparities\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.arisglobal.com\/"},{"@type":"ListItem","position":2,"name":"National Pharmacovigilance Systems &#038; Role of Technology in Bridging the Disparities"}]},{"@type":"WebSite","@id":"https:\/\/www.arisglobal.com\/#website","url":"https:\/\/www.arisglobal.com\/","name":"ArisGlobal","description":"","publisher":{"@id":"https:\/\/www.arisglobal.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.arisglobal.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.arisglobal.com\/#organization","name":"LifeSphere","url":"https:\/\/www.arisglobal.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.arisglobal.com\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"LifeSphere"},"image":{"@id":"https:\/\/www.arisglobal.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/LifeSphereAG\/","https:\/\/www.linkedin.com\/products\/aris-global-lifesphere\/"]},{"@type":"Person","@id":"https:\/\/www.arisglobal.com\/#\/schema\/person\/bb2c7aafe44a090bcd667448651eb974","name":"Mladen Prenc"}]}},"_links":{"self":[{"href":"https:\/\/www.arisglobal.com\/wp-json\/wp\/v2\/posts\/14003"}],"collection":[{"href":"https:\/\/www.arisglobal.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.arisglobal.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.arisglobal.com\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/www.arisglobal.com\/wp-json\/wp\/v2\/comments?post=14003"}],"version-history":[{"count":0,"href":"https:\/\/www.arisglobal.com\/wp-json\/wp\/v2\/posts\/14003\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.arisglobal.com\/wp-json\/wp\/v2\/media?parent=14003"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.arisglobal.com\/wp-json\/wp\/v2\/categories?post=14003"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.arisglobal.com\/wp-json\/wp\/v2\/tags?post=14003"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}